Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Guido Siffredi"'
Autor:
Elisabetta Bonzano, Guido Siffredi, M. Gusinu, Renzo Corvò, E Vaccara, Daniele Friedman, Marina Guenzi, S. Garelli, Piero Fregatti, Liliana Belgioia, Giorgia Polizzi
Aim To evaluate once-weekly hypofractionated radiotherapy in elderly patients affected by early breast cancer, reporting acute and late toxicity profiles, and treatment feasibility. Patients and methods Fifty patients were treated with a hypofraction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa82c8f92675e47d4908428d2621e4c
http://hdl.handle.net/11567/983907
http://hdl.handle.net/11567/983907
Autor:
Silvia Genestroni, Ajay Ram Vachanaram, Veronica Martini, Simone Nardin, Guido Siffredi, Edoardo Mora, Feba mariam Varughese, Alessandra Gennari, Ilaria Repetti, Paolo Bruzzi, David J. Pinato, G. Borra, Federica Biello, Antonio Sica
Publikováno v:
Web of Science
e15263 Background: The introduction of immune check-point inhibitors (ICIs) in the treatment of a broad range of tumor types has led to a significant and clinically meaningful improvement in overall survival (OS) in advanced disease stages. However,
Autor:
Francesca, Vallerga, Marco, Orsatti, Francesca, Maggio, Salvina, Barra, Renato, Chiarlone, Claudio, Arboscello, Tindaro, Scolaro, Filippo, Grillo Ruggieri, Guido, Siffredi, Bonzano, Elisabetta, Corvo', RENZO GIACINTO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3710::f6fe5d9332f60f82b215c03ccb9981fd
http://hdl.handle.net/11567/822207
http://hdl.handle.net/11567/822207
Autor:
Marina Guenzi, Davide Bosetti, F. Pupillo, Elisabetta Bonzano, Renzo Corvò, S. Garelli, G. Lamanna, M. Gusinu, Guido Siffredi
Publikováno v:
Tumori. 101(2)
Background The aim of this study was to evaluate retrospectively the planned dose distribution and acute toxicity of adjuvant hypofractionated whole breast radiotherapy (RT) delivered in the prone vs. supine position. Methods Twenty-four patients wer
Autor:
Guido Siffredi, G. Gardin, Clara Monzeglio, Mario Roberto Sertoli, Davide Bedognetti, Lucia Del Mastro, Paola Taveggia, Francesco Boccardo, Paolo Bruzzi, S. Pastorino, Elisa Zanardi, Marco Venturini, Ena Wang, Paolo Pronzato, Paola Queirolo
The most appropriate timing of chemotherapy and hormone therapy administration is a critical issue in early breast cancer patients. The purpose of our study was to compare the efficacy of concurrent vs sequential administration of adjuvant chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4467d5413af0b418650e6da8fcd0ff3
http://hdl.handle.net/11567/277150
http://hdl.handle.net/11567/277150
Autor:
Francesco M. Marincola, Stefania Santamaria, Mario Roberto Sertoli, Andrea De Maria, Nicoletta Provinciali, Gabriele Zoppoli, Carlotta Massucco, Elisa Zanardi, Francesco Ricci, Filippo Ansaldi, Guido Siffredi, Marco Messina, Simonetta Zupo, Davide Bedognetti, Lorenzo Uccellini, Graziano Caltabiano, Giovanna Schiavone, Pietro Blandini, Silvia Sanguineti
Publikováno v:
Clinical Immunology. 135:S84
Autor:
Davide Bedognetti, Alessio Nencioni, Marco Messina, Marianna Sabatino, Pos Zoltan, Carlotta Massucco, Andrea De Maria, Elisa Zanardi, Guido Siffredi, Nicoletta Provinciali, Andrea Bruzzone, Maria Libera Ascierto, Lorenzo Uccellini, Graziano Caltabiano, Gabriele Zoppoli, Simonetta Zupo, Omar Racchi, Francesco M. Marincola, Manlio Ferrarini, Riccardo Ghio, Mario Roberto Sertoli, Filippo Ansaldi
Publikováno v:
Publons
Abstract 936 1 Background. Rituximab, anti-CD20 mAb, has become an essential drug for the treatment of Non Hodgkin Lymphoma (NHL). Although transient B cells depletion frequently occurs after Rituximab treatment, it usually resolves after 6-9 months.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d82aa5725712c57bf76ec68ee36597b
https://publons.com/publon/6648596/
https://publons.com/publon/6648596/